IDE892

· IDEAYA Biosciences

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for IDE892, covering 2026-04-03 to 2026-04-03. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors [Phase 1]